Dow Down 0.04% Nasdaq Up 0.77%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
14.42 Up 0.13(0.89%) 3:30PM EST - Nasdaq Real Time Price
Prev Close:14.29
Open:14.28
Bid:14.34 x 200
Ask:14.39 x 300
1y Target Est:25.25
Beta:3.79
Next Earnings Date:N/A
Day's Range:14.02 - 14.68
52wk Range:12.50 - 21.40
Volume:296,592
Avg Vol (3m):236,589
Market Cap:379.08M
P/E (ttm):N/A
EPS (ttm):-3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXUp 0.89%379.08M
GSKDown 0.23%111.29B
MRKDown 0.99%168.40B
RHHBYDown 0.13%253.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.70
Quarterly EPS Est (Dec-14) :-1.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback